Anti-D Immunoglobulin Market Report 2026
Download Free Sample Buy Now
Anti-D Immunoglobulin Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anti-D Immunoglobulin Market Report 2026

Global Outlook – By Product Type (Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel), By Application (Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications), By End-User (Hospitals, Clinics, Blood Banks, Research Laboratories) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Anti-D Immunoglobulin Market Overview

• Anti-D Immunoglobulin market size has reached to $2.59 billion in 2025

• Expected to grow to $3.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Rise In Global Birth Rates Fueling The Growth Of The Market Due To Increasing Risk Of Rh Incompatibility

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anti-D Immunoglobulin Market?

Anti-D immunoglobulin is a specialized blood product derived from human plasma that contains antibodies against the RhD antigen found on red blood cells. It is produced by collecting plasma from donors who have been sensitized to the RhD antigen, followed by purification and concentration of the specific immunoglobulin G (IgG) antibodies.

The main product types of anti-D immunoglobulin are intramuscular anti-D immunoglobulin and intravenous anti-D immunoglobulin. Intramuscular anti-D immunoglobulin is a plasma-derived antibody preparation administered into muscle tissue to prevent Rh incompatibility in Rh-negative individuals by neutralizing Rh-positive fetal red blood cells. These are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used in various applications such as hemolytic disease of the newborn, immune thrombocytopenic purpura, antenatal and postnatal prophylaxis, and others. It is used by several end-users, such as hospitals, clinics, blood banks, and research laboratories.

Anti-D Immunoglobulin Market Global Report 2026 Market Report bar graph

What Is The Anti-D Immunoglobulin Market Size and Share 2026?

The anti-d immunoglobulin market size has grown strongly in recent years. It will grow from $2.59 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to limited plasma donor pools, reliance on manual antibody extraction processes, growing awareness of hemolytic disease, increasing hospital and clinical usage, adoption of intramuscular administration.

What Is The Anti-D Immunoglobulin Market Growth Forecast?

The anti-d immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $3.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of intravenous formulations, expansion of automated plasma fractionation technologies, rising antenatal screening programs, increasing global blood bank infrastructure, growth in personalized immunoglobulin therapies. Major trends in the forecast period include rising demand for anti-d immunoglobulin in hemolytic disease management, increasing adoption of pre-filled syringes and single-use vials, expansion of antenatal and postnatal prophylaxis programs, growth in hospital and blood bank-based distribution channels, enhanced focus on safety, purity, and regulatory compliance.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Anti-D Immunoglobulin Market Segmentation

1) By Product Type: Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

3) By Application: Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications

4) By End-User: Hospitals, Clinics, Blood Banks, Research Laboratories

Subsegments:

1) By Intramuscular Anti-D Immunoglobulin: Standard Dose, High Dose, Pre-Filled Syringes, Vials

2) By Intravenous Anti-D Immunoglobulin: Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials

What Are The Drivers Of The Anti-D Immunoglobulin Market?

The high birth rates are expected to propel the growth of the anti-D immunoglobulin market going forward. Birth rates represent the number of live births recorded annually for every 1,000 people in a population. Birth rates are increasing due to insufficient access to education and family planning services, resulting in higher fertility and larger families. Anti-D immunoglobulin helps birth rates by preventing Rh incompatibility in pregnancy, which reduces the risk of hemolytic disease in newborns and supports healthier outcomes in future pregnancies. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, there were 3,622,673 recorded births in 2024, reflecting a 1% increase from 2023. Therefore, the high birth rates are driving the growth of the anti-D immunoglobulin industry.

The expanding healthcare infrastructure is expected to propel the growth of the anti-D immunoglobulin market going forward. Healthcare infrastructure refers to the system of facilities, equipment, workforce, and support mechanisms essential for delivering healthcare services within a population. Healthcare infrastructure is expanding as a result of the growing global population, which drives higher demand for medical care and necessitates the development of more hospitals, clinics, and related resources. Healthcare infrastructure expansion enhances access to maternal healthcare, enabling better screening and timely use of anti-D immunoglobulin to prevent hemolytic disease in newborns. For instance, in May 2023, according to the Department of Health and Social Care, a UK-based government department, the government announced plans to allocate more than $27 billion (£20 billion) toward building new hospital facilities. As part of the New Hospital Programme, two hospitals are already finished, five are currently being built, and over 20 are set to be underway or completed by the end of 2023. Therefore, the expanding healthcare infrastructure is driving the growth of the anti-D immunoglobulin industry.

The expansion of prenatal and antenatal screening programs is expected to propel the growth of the anti D immunoglobulin market going forward. Prenatal and antenatal screening involves testing pregnant women for blood group compatibility and fetal RhD genotype to prevent hemolytic disease of the fetus and newborn. The expansion of these screening programs is due to the adoption of noninvasive prenatal testing (NIPT) using cell-free fetal DNA, which allows accurate identification of fetal RhD status. Prenatal and antenatal screening programs support the effective use of Anti-D immunoglobulin by identifying Rh-negative mothers early in pregnancy, monitoring for any potential sensitisation events, and ensuring timely intervention to prevent Rh incompatibility and protect both maternal and fetal health. For instance, in July 2025, according to the World Health Organization (WHO), a Switzerland-based international public health agency, an estimated 1.2 million pregnant women were living with HIV in 2023, of whom about 84% received antiretroviral medicines to prevent mother-to-child transmission. Therefore, the expansion of prenatal and antenatal screening programs is driving the growth of the anti D immunoglobulin market.

Key Players In The Global Anti-D Immunoglobulin Market

Major companies operating in the anti-d immunoglobulin market are CSL Behring, Octapharma AG, Kedrion Biopharma Inc., Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kamada Pharmaceuticals, Saol Therapeutics Inc., Avin Darou, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Taj Pharmaceuticals Limited, Aetos Pharma Private Limited, PV Pharma Healthcare Pvt. Ltd., Grifols S.A., Takeda Pharmaceutical Company Limited, LFB Biomedicaments, China Biologic Products Holdings Inc., Shanghai RAAS Blood Products Co. Ltd., Hualan Biological Engineering Inc., CBPO (Shandong Taibang Biological Products Co. Ltd.), Bio Products Laboratory (BPL), Instituto Grifols S.A., HemaCare Corporation, KM Biologics Co. Ltd., National Bioproducts Institute (NBI), GC Pharma (Green Cross Corporation), SK Plasma Co. Ltd.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the anti-D immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-D Immunoglobulin Market?

The anti-D immunoglobulin market consists of sales of hepatitis B immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, and varicella-zoster immunoglobulin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-D Immunoglobulin Market Report 2026?

The anti-d immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-d immunoglobulin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anti-D Immunoglobulin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.76 billion
Revenue Forecast In 2035 $3.55 billion
Growth Rate CAGR of 6.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Distribution Channel, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled CSL Behring, Octapharma AG, Kedrion Biopharma Inc., Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kamada Pharmaceuticals, Saol Therapeutics Inc., Avin Darou, S
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anti-D Immunoglobulin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anti-D Immunoglobulin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anti-D Immunoglobulin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anti-D Immunoglobulin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Anti-D Immunoglobulin In Hemolytic Disease Management

4.2.2 Increasing Adoption Of Pre-Filled Syringes And Single-Use Vials

4.2.3 Expansion Of Antenatal And Postnatal Prophylaxis Programs

4.2.4 Growth In Hospital And Blood Bank-Based Distribution Channels

4.2.5 Enhanced Focus On Safety, Purity, And Regulatory Compliance

5. Anti-D Immunoglobulin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Blood Banks

5.4 Research Laboratories

5.5 Pharmaceutical Manufacturers

6. Anti-D Immunoglobulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-D Immunoglobulin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-D Immunoglobulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anti-D Immunoglobulin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anti-D Immunoglobulin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anti-D Immunoglobulin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-D Immunoglobulin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-D Immunoglobulin Market Segmentation

9.1. Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin

9.2. Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

9.3. Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications

9.4. Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Blood Banks, Research Laboratories

9.5. Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Dose, High Dose, Pre-Filled Syringes, Vials

9.6. Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials

10. Anti-D Immunoglobulin Market Regional And Country Analysis

10.1. Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-D Immunoglobulin Market

11.1. Asia-Pacific Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-D Immunoglobulin Market

12.1. China Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-D Immunoglobulin Market

13.1. India Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-D Immunoglobulin Market

14.1. Japan Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-D Immunoglobulin Market

15.1. Australia Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-D Immunoglobulin Market

16.1. Indonesia Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-D Immunoglobulin Market

17.1. South Korea Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-D Immunoglobulin Market

18.1. Taiwan Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-D Immunoglobulin Market

19.1. South East Asia Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-D Immunoglobulin Market

20.1. Western Europe Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-D Immunoglobulin Market

21.1. UK Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-D Immunoglobulin Market

22.1. Germany Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-D Immunoglobulin Market

23.1. France Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-D Immunoglobulin Market

24.1. Italy Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-D Immunoglobulin Market

25.1. Spain Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-D Immunoglobulin Market

26.1. Eastern Europe Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-D Immunoglobulin Market

27.1. Russia Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-D Immunoglobulin Market

28.1. North America Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-D Immunoglobulin Market

29.1. USA Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-D Immunoglobulin Market

30.1. Canada Anti-D Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-D Immunoglobulin Market

31.1. South America Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-D Immunoglobulin Market

32.1. Brazil Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-D Immunoglobulin Market

33.1. Middle East Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-D Immunoglobulin Market

34.1. Africa Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anti-D Immunoglobulin Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-D Immunoglobulin Market Regulatory and Investment Landscape

36. Anti-D Immunoglobulin Market Competitive Landscape And Company Profiles

36.1. Anti-D Immunoglobulin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anti-D Immunoglobulin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anti-D Immunoglobulin Market Company Profiles

36.3.1. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Kedrion Biopharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanquin Overview, Products and Services, Strategy and Financial Analysis

37. Anti-D Immunoglobulin Market Other Major And Innovative Companies

Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kamada Pharmaceuticals, Saol Therapeutics Inc., Avin Darou, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Taj Pharmaceuticals Limited, Aetos Pharma Private Limited, PV Pharma Healthcare Pvt. Ltd., Grifols S.A., Takeda Pharmaceutical Company Limited, LFB Biomedicaments, China Biologic Products Holdings Inc.

38. Global Anti-D Immunoglobulin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-D Immunoglobulin Market

40. Anti-D Immunoglobulin Market High Potential Countries, Segments and Strategies

40.1 Anti-D Immunoglobulin Market In 2030 - Countries Offering Most New Opportunities

40.2 Anti-D Immunoglobulin Market In 2030 - Segments Offering Most New Opportunities

40.3 Anti-D Immunoglobulin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anti-D Immunoglobulin Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anti-D Immunoglobulin Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anti-D Immunoglobulin Market, Supply Chain Analysis
  • Table 4: Global Anti-D Immunoglobulin Market, Major Raw Material Providers
  • Table 5: Global Anti-D Immunoglobulin Market, Major Resource Providers
  • Table 6: Global Anti-D Immunoglobulin Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anti-D Immunoglobulin Market, Major Distributors And Channel Partners
  • Table 8: Global Anti-D Immunoglobulin Market, Key Technologies & Future Trends
  • Table 9: Global Anti-D Immunoglobulin Market, Major Trends
  • Table 10: Global Anti-D Immunoglobulin Market, Major End Users
  • Table 11: Global Anti-D Immunoglobulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anti-D Immunoglobulin Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anti-D Immunoglobulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anti-D Immunoglobulin Market - TAM, US$ Billion, 2025
  • Table 15: Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Anti-D Immunoglobulin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Anti-D Immunoglobulin Market - Company Scoring Matrix
  • Table 97: CSL Behring Financial Performance
  • Table 98: Octapharma AG Financial Performance
  • Table 99: Kedrion Biopharma Inc. Financial Performance
  • Table 100: Biotest AG Financial Performance
  • Table 101: Sanquin Financial Performance
  • Table 102: Global Anti-D Immunoglobulin Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Anti-D Immunoglobulin Market, Competitive Dashboard
  • Table 104: Global Anti-D Immunoglobulin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 106: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 107: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Anti-D Immunoglobulin Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anti-D Immunoglobulin Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anti-D Immunoglobulin Market, Supply Chain Analysis
  • Figure 4: Global Anti-D Immunoglobulin Market, Major Raw Material Providers
  • Figure 5: Global Anti-D Immunoglobulin Market, Major Resource Providers
  • Figure 6: Global Anti-D Immunoglobulin Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anti-D Immunoglobulin Market, Major Distributors And Channel Partners
  • Figure 8: Global Anti-D Immunoglobulin Market, Key Technologies & Future Trends
  • Figure 9: Global Anti-D Immunoglobulin Market, Major Trends
  • Figure 10: Global Anti-D Immunoglobulin Market, Major End Users
  • Figure 11: Global Anti-D Immunoglobulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anti-D Immunoglobulin Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anti-D Immunoglobulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anti-D Immunoglobulin Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Anti-D Immunoglobulin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Anti-D Immunoglobulin Market - Company Scoring Matrix
  • Figure 97: CSL Behring Financial Performance
  • Figure 98: Octapharma AG Financial Performance
  • Figure 99: Kedrion Biopharma Inc. Financial Performance
  • Figure 100: Biotest AG Financial Performance
  • Figure 101: Sanquin Financial Performance
  • Figure 102: Global Anti-D Immunoglobulin Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Anti-D Immunoglobulin Market, Competitive Dashboard
  • Figure 104: Global Anti-D Immunoglobulin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 106: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 107: Global, Anti-D Immunoglobulin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Immunoglobulins Market Report 2026 - Global Outlook – By Product (IGG, IGA, IGM, IGE, IGD), By Mode Of Delivery (Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery), By Application (Hypogammaglobulinemia, Chroni...

Intravenous Immunoglobulin Market Report 2026 - Global Outlook – By Type (IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel (...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunotoxin Market Report 2026 - Global Outlook – By Type (Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonu...

Autoimmune Treatment Market Report 2026 - Global Outlook – By Service Type (Consultation And Diagnosis, Therapy And Monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s...

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2026 - Global Outlook – By Product (Cardiac Markers, Metabolic Markers, Renal Markers, Other Products), By Source Animal (Goat, Rabbit, Horse, Mouse, Oth...

Subcutaneous Immunoglobulin (SCIG) Market Report 2026 - Global Outlook – By Product Type (Immunoglobulin A (IgA), Immunoglobulin G (IgG)), By Application (Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurolog...

Allergy Immunotherapy Market Report 2026 - Global Outlook – By Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies), By Treatment (Subcutaneous ...

Frequently Asked Questions

The Anti-D Immunoglobulin market was valued at $2.59 billion in 2025, increased to $2.76 billion in 2026, and is projected to reach $3.55 billion by 2030.

The global Anti-D Immunoglobulin market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $3.55 billion by 2035.

Some Key Players in the Anti-D Immunoglobulin market Include, CSL Behring, Octapharma AG, Kedrion Biopharma Inc., Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kamada Pharmaceuticals, Saol Therapeutics Inc., Avin Darou, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Taj Pharmaceuticals Limited, Aetos Pharma Private Limited, PV Pharma Healthcare Pvt. Ltd., Grifols S.A., Takeda Pharmaceutical Company Limited, LFB Biomedicaments, China Biologic Products Holdings Inc., Shanghai RAAS Blood Products Co. Ltd., Hualan Biological Engineering Inc., CBPO (Shandong Taibang Biological Products Co. Ltd.), Bio Products Laboratory (BPL), Instituto Grifols S.A., HemaCare Corporation, KM Biologics Co. Ltd., National Bioproducts Institute (NBI), GC Pharma (Green Cross Corporation), SK Plasma Co. Ltd. .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the anti-D immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-d immunoglobulin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us